Back to EZorb Newsletter Index

EZorb

  

EZORB MONTHLY NEWSLETTER MAR 28, 2019

In this issue:

 

1. Share Success: Letters From Readers
2. Research News: Type 2 Diabetes Patients Benefit From HIIT Plus Resistance Training
3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb and Marvlix?
  

1. Share Success: Letters From Readers 


Letter I: From Michael P. M.

Received at Share Success Thursday, February 7, 2019, 1:43 PM PST

(Unedited)

 

I am 67 year old man. I was diagnosed with extreme osteoarthritis after I nearly starved to death when I lost 125 pounds after colostomy reversal surgery.

I started taking EZorb Powder last Tuesday night and this Thursday morning and all day long I am experiencing new tingling sensations in all my joints.

I assume this is a very good sign as this morning is the first time in 3 years that I could easily stand up without using my hands to push myself up.

Does this sound like what might normally be expected. I am ordering more bottles today. I will keep you posted as I progress.

God Bless you for this product.

Michael P M., MBA/BSChE


Letter II: From Judy

Received at Testimonial Submit Form Friday, January 18, 2019, 9:55 AM PST

(Unedited)

 

Hi, my name is Judy.

Thank you so much for the medical staff's support along with Ezorb calcium product that cured bone spur I've had for the past 7months.

I had to quit hiking as well as walking exercises I've enjoyed for many years due to pain on my left foot with bone spur.

I didn't bother to f/u with the medical doctor. But after found Ezorb online and read upon many testimonies, I immediately went on Ezorb, double dosing for the past two and a half months.

I stuck with the regime, for I sensed gradual improvement with pain as I pressed down on the heel.

Then within less than three months, I didn't feel bone spur as I stayed on my feet for a while. And I knew the spur has resolved.

I feel so liberated from having to restrict being on my feet for an extended period of time. I thank God for leading me to this website!


Letter III: From Ruth F. C.

Received at Customer Service Friday, December 7, 2018, 9:40 PM

(Unedited)

 

Good People:

I am a customer of Ezorb for the past 3 years.

My last blood test left no doubts my consistently good level of calcium is the result of taking EZorb daily. I have significant improvement in my bone mass and a bone scan was not recommended at my last Dr. Visit.

The reason I am sending this email is that I feel so good about EZorb that I feel the good news concerning this product needs to be shared.

I spoke to Barbara J. of (name removed for privacy) Spa in Punta Gorda Florida where I go and discussed EZorb with her. I shared the pharmacology from your web site and she said she would call and see if Ezorb could be offered for the Spa clients. I told her I highly recommend the product and along with a healthy lifestyle deserves credit for keeping my bones strong. So hopefully many of the clients will benefit.

I just started taking Marvlix . My cholesterol is good but I would like to get the total to 150.

My husband takes Marvlix and is off his Statin prescription with total cholesterol of 188.

Thank you for excellent products.
Ruth C., Age 80


***************************************************

From the Desk of EZorb Newsletter Editor:

 
This newsletter is now read by over 120,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's quality of life. Your continuous support will be greatly appreciated by tens of thousands who have been suffering and would continuously suffer, without your help! Please email your story to sharesuccess @ ezorbonline.com or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public. We appreciate your effort.


2. Research News: Type 2 Diabetes Patients Benefit From HIIT Plus Resistance Training

 

A 1-year exercise intervention combining high-intensity interval training (HIIT) with resistance training may improve measures of cardiovascular risk among people with type 2 diabetes, suggests a secondary analysis of the D2FIT trial.

Previously reported findings from this trial – in which 80 participants were randomly assigned to take part in an intervention combining either HIIT or moderate continuous training (MCT) plus resistance training, or a control intervention involving standard advice on physical activity – showed no impact of HIIT plus resistance training on body composition or glycemic control, say Luís Sardinha (Universidade de Lisboa, Portugal) and co-investigators.

Nevertheless, the present analysis demonstrated that both the HIIT and MCT programs were associated with a reduction in carotid intima-media thickness (cIMT), and the HIIT intervention was also associated with improvement in indices of peripheral arterial stiffness, they report in Cardiovascular Diabetology.

Specifically, individuals in the HIIT group experienced a reduction in mean cIMT from 733.6 mm at baseline to 724.1 mm at the 1-year follow-up, while those in the MCT group had a reduction from 737.9 mm to 712.3 mm. Conversely, average cIMT increased from 714.9 mm to 751.2 mm over the 1-year period among people in the control group.

"The fact that a 1-year intervention promoted a significant reduction in cIMT is important because the carotid artery is highly susceptible to the development of atherosclerosis and is an important marker for identifying patients who are at higher risk of developing micro- and macrovascular complications," write Sardinha and colleagues.

The team found that the arterial stiffness indices carotid to distal pulse wave velocity (CD PWV) and carotid radial pulse wave velocity (CR PWV) both decreased in the HIIT group, from 9.7 m/s and 9.5 m/s, respectively, at baseline, to a corresponding 8.6 m/s and 8.3 m/s at the 1-year follow-up. However, these measures remained similar or increased over the study period among individuals in the MCT and control groups.

These findings highlight "HIIT as a promising long-term exercise strategy to delay and counter the changes in arterial stiffness indices," write the researchers, adding that such indices are "typically compromised in ageing and in type 2 diabetes, with likely implications on the progression of cardiovascular disease."

They conclude that the D2FIT results "may have future implications for exercise interventions in patients with type 2 diabetes with goals of targeting and attenuating the micro- and macrovascular changes inherent to this disease."

Original article appeared in 22-03-2019 | Cardiovascular | News | Article


3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

  

 

4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ elixirindustry.com for a copy of the instructions.

 

 

5. What Are Others Saying About EZorb and Marvlix?

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.

 

Back to EZorb Newsletter Index

 
  Copyright 2019 Elixir Industry